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Conclusion: A reasonable high correlation in response during 
chemoradiation between the primary lung tumour and lymph 
nodes was observed, but a large inter- and intra-patient 
variability was observed. These preliminary results suggest 
that treatment plan modification based on metabolic 
treatment response should be tailored to individual lesions.  
[1] van Elmpt et al., J Nucl Med. 2012 
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Purpose or Objective: Apparent diffusion coefficient (ADC), 
derived from diffusion-weighted MRI (DW-MRI) is a promising 
assessment method during radiotherapy treatment, but 
geometric distortion is its main disadvantage. This study 
investigates the use of the reversed gradient method (RGM) 
in DW-MRI for reduction in geometric distortion and 
vascularization from dynamic studies of MRI (DCEMRI), as a 
surrogate measure of oxygenation in H&N cancer. 
 
Material and Methods: We studied the variation of ADC of 
three oropharynx cancer patients included in ARTFIBIO 
project. Three functional imaging scans were performed 
before treatment: PET/CT, DWMRI and DCEMRI; two MRI 
scans during the treatment; and three months after the 
treatment, the initial studies were repeated. Geometric 
distortion of DWMRI was corrected using RGM (SPM8 software, 
HySCO options). DCEMRI analyses were performed using 
Dynamika® v4.0 (www.imageanalysis.org.uk). Registration 
and mutual information were calculated with ARTFIBio tools. 
Mutual information of T2-weighted and DW-MRI was 
calculated for corrected and uncorrected DW-MRI. Initial 
Rate Enhancement (IRE) from DCEMRI was selected as a 
possible biomarker associated with vascularization / hypoxia. 
 
Results: Table shows the increment in mutual information for 
the initial ADC maps of the three patients when correcting by 
RGM. For two first patients, a large increment is observed 
and for the third patient, although the mutual information 
didn’t show it, the visual appreciation is quite relevant. In 
Figure A, the visual improvement of corrected images can be 
appreciated. 
We also measured the variation of ADC during the treatment 
(Figure B), and three months later. The colour in the dots 
shows the initial IRE values in arbitrary units. As the dose is 
delivered, best-vascularized dots move to the upper part of 
the cloud corresponding to different instants along the 
treatment. 
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by 
Reversed 
gradient 
#1 0.563 0.656 0.872 0.655 0.325 0.900 
#2 0.308 0.454 0.775 0.381 0.445 0.730 
#3 0.439 0.548 0.548 0.545 0.522 0.567 
 
Conclusion: RGM improves registration and provides accurate 
ADC in tumors. We suggest correction of distortion with the 
RGM should form part of an imaging method for treatment 
response using ADC to assess tumor response or tumor cell 
density variation with treatment in cancer patients, and 
DCEMRI can be useful for characterizing hypoxia in H&N 
cancers. Supported by ISCIII Grant DTS14/00188 
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Purpose or Objective: High dose lung-sparing pleural 
radiotherapy for malignant pleural mesothelioma (MPM) is 
difficult. Accurate target delineation is critical. The optimal 
imaging modality to define radiotherapy target volumes has 
not been studied in depth. This is the aim of the present 
study.  
 
Material and Methods: Twelve consecutive patients with a 
histopathological diagnosis of stage I-IV MPM (6 left-sided and 
6 right-sided) were included. CT scans with IV contrast, 18F-
FDG PET/CT scans and MRI scans (post-contrast T1-weighted, 
T2 and diffusion-weighted images [DWI]) were obtained and 
downloaded from the institutional database onto a 
standalone image fusion workstation (MIM Software Inc., 
Cleveland, OH, USA) for image registration and contouring. 
CT scans were rigidly co-registered with 18FDG-CT-PET, with 
MRI scans and with DWI scans. Four sets of pleural GTVs were 
defined: 1) a CT-based GTV (GTVCT); 2)a PET/CT-based GTV 
(GTVCT+PET/CT); 3) a T1/T2-weighted MRI-based GTV 
(GTVCT+MRI); 4) a DWI-based GTV (GTVCT+DWI). Only the 
pleural tumor was contoured; mediastinal nodes were 
excluded. “Quantitative” and “qualitative” (visual) 
evaluation of the volumes was performed. 
 
Results: Compared to CT-based GTV definition, PET/CT 
identified additional tumour sites in 12/16 patients. 
Compared to either CT or PET/CT, MRI and DWI identified 
additional tumour sites in 15/16 patients. Mean GTVCT, 
GTVCT+PET/CT, GTVCT+MRI and GTVCT+DWI (+ standard 
deviation [SD]) were respectively 630.1 mL (+302.81), 640.23 
(+302.83), 660.8 (+290.8) and 655.2 mL(+290.7). Mean 
Jaccard index was lower in MRI-based contours versus all the 
others. 
 
Conclusion: To the best of our knowledge, this is the first 
study showing that the integration of MRI into the target 
volume definition in hemithoracic radiotherapy in MPM may 
allow to improve the accuracy of target delineation and 
reduce the likelihood of geographical misses.  
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Purpose or Objective: Texture and shape metrics are 
increasingly used for oncological applications such as the 
prediction of response to therapy. Commercial and freely 
available software tools have been used to publish significant 
results. However, it is unclear if these tools provide matched 
or even similar values, which is crucial when comparing such 
studies and drawing conclusions affecting patient 
management. In this work, we benchmark texture analysis 
software for PET in oesophageal cancer. 
 
Material and Methods: PET-STAT, a texture analysis tool 
written in the Matlab-based open source software CERR, was 
benchmarked against the open source software CGITA and 
the Radiomics package, on oesophageal cancer PET-CT scans. 
The PET scans and tumour outlines in DICOM format were 
processed on-site with PET-STAT and CGITA and remotely for 
Radiomics. Image resampling in PET-STAT matched the 
number of discrete intensities used in CGITA, where it was 
fixed, and in Radiomics, where the image bin width was set 
to 0.5 SUV. Texture and shape metrics present in PET-STAT 
and Radiomics or CGITA were matched by their mathematical 
description. The metrics calculated were Maximum, Mean 
intensity, SUVpeak, Volume, Total Lesion Glycolysis; 
histogram-based Standard Deviation, Skewness, Kurtosis, 
Entropy (HEp) and Energy; grey level cooccurrence matrix 
(GLCM)-based Entropy, Homogeneity and Dissimilarity; 
Coarseness (C); grey level size-zone-based Intensity 
Variability, Large Area Emphasis and Zone Percentage, and 
shape metrics Maximum Diameter, Compactness, Sphericity, 
Spherical disproportion. No C was found in Radiomics, no 
shape metrics nor HEp were found in CGITA. 
 
Results: Differences up to 7% in volume were observed 
between PET-STAT and CGITA, which disappeared when using 
data loaded from CERR, were due to different interpretation 
of the DICOM images and outline data. Errors of 7% in volume 
in one case compared with Radiomics may be due to different 
RTSTRUCT export or import in the study workflow. SUVpeak 
was up to 12% different between software packages due to 
different hard coded resampling of the PET image or kernel 
sizes used. Differences of up to 44% were observed in the 
calculation of shape metrics between Radiomics and PET-
STAT. This was due to differences in the triangulation 
technique used to calculate the contour surface area. 
Furthermore, differences of up to 30% across the cases 
considered, were found to be due to different equations used 
for resampling the image to discrete intensities, as well as 
different methods for computing the GLCM and GLSZM. 
 
 
 
Conclusion: Our benchmarking work on oesophageal cancer 
PET imaging reported a number of non trivial differences in 
texture and shape metric values when using different 
software packages. This highlights the importance of 
commissioning and validating texture analysis tools and 
recommends that detailed descriptions of the metric and 
software implementation are available.  
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Purpose or Objective: Biologically guided radiotherapy 
needs an understanding of how different functional imaging 
techniques link together. We analyse three functional 
imaging techniques that can be useful to characterize tumour 
behaviour: DWMRI, DCEMRI and PET/CT with FDG. 
 
